Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantROCHE SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INFUSION, SOLUTION CONCENTRATE
INTRAVENOUS
Medical Information
L01FX25
Manufacturer Information
ROCHE SINGAPORE PTE. LTD.
Genentech, Inc.
Active Ingredients
Documents
Package Inserts
Lunsumio infusion PI.pdf
Approved: May 8, 2024